Next Article in Journal
Evaluation of Optimized Tube-Gel Methods of Sample Preparation for Large-Scale Plant Proteomics
Next Article in Special Issue
Proteome Profiling of Diabetic Mellitus Patient Urine for Discovery of Biomarkers by Comprehensive MS-Based Proteomics
Previous Article in Journal
Acknowledgement to Reviewers of Proteomes in 2017
Previous Article in Special Issue
Quantification of Cardiovascular Disease Biomarkers in Human Platelets by Targeted Mass Spectrometry
Article Menu

Export Article

Open AccessFeature PaperReview
Proteomes 2018, 6(1), 5; doi:10.3390/proteomes6010005

Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers

1
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A1, Canada
2
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON M5T 3L9, Canada
3
Centre for Prognosis Studies in Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON M5T 1M8, Canada
4
Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, ON M5T 1A1, Canada
5
Institute of Medical Science, University of Toronto, Toronto, ON M5T 1A1, Canada
*
Author to whom correspondence should be addressed.
Received: 18 December 2017 / Revised: 16 January 2018 / Accepted: 21 January 2018 / Published: 24 January 2018
(This article belongs to the Special Issue Proteomic Biomarkers in Human Diseases)
View Full-Text   |   Download PDF [421 KB, uploaded 24 January 2018]   |  

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis which develops in up to one-third of patients suffering from the cutaneous disorder, psoriasis. The complex and heterogeneous nature of PsA renders it difficult to diagnose, leading to poor outcomes and, therefore, warrants an examination into soluble biomarkers, which may facilitate early detection of the disease. Protein biomarkers are a dynamic resource of pathophysiological information able to provide an immediate reflection of pathological changes caused by disease. Investigations of the serum and synovial fluid of PsA patients has provided new insights into the molecular basis of this disease and led to the identification of sensitive diagnostic and prognostic biomarkers. The collection of novel PsA biomarkers identified through proteomic studies has been reviewed below. View Full-Text
Keywords: proteomics; biomarkers; psoriatic arthritis; serum; synovial fluid proteomics; biomarkers; psoriatic arthritis; serum; synovial fluid
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Mahendran, S.M.; Chandran, V. Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers. Proteomes 2018, 6, 5.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Proteomes EISSN 2227-7382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top